
About Innoventric
Innoventric is a Healthcare company based in Ness Ziona (Israel) founded in 2017 by Rafi Benary. Transcatheter solutions for heart disease patients are developed. Innoventric has raised $41.81 million across 4 funding rounds from investors including RA Capital, European Union and Mivtach Shamir Holdings. Innoventric offers products and services including Trillium, Unica, and Koala. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Innoventric Ltd.
Company details
Founded in 2017 in Ness Ziona, Israel, transcatheter solutions are developed for patients with heart diseases. Focus is placed on percutaneous devices, including the Trillium, which addresses tricuspid regurgitation through minimally invasive procedures. Operations occur within the medical device sector, emphasizing cardiovascular treatments. Geography is centered in Israel, with activities aimed at advancing interventional cardiology options for clinical use.
- Headquarters Ness Ziona, Israel
- Founders Rafi Benary
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website innoventric.com
- Social LinkedIn YouTube
- Legal Name Innoventric Ltd.
- Total Equity Funding$41.81M (USD)
in 4 rounds
- Latest Funding Round$28.5M (USD), Series B
Oct 2024
- InvestorsRA Capital
& 5 more
Products & Services of Innoventric
Innoventric offers a comprehensive portfolio of products and services, including Trillium, Unica, and Koala.
Device for quick TR treatment with hemodynamic improvements.
Heterotopic solution for TR patients via cross-caval technology.
Supportive device for TR management in clinical settings.
Apps and channels of Innoventric
its YouTube channel PCR has 17.9K subscribers and 30 videos.
Videos from Innoventric
The most watched videos on Innoventric's YouTube channel, PCR (17.9K subscribers). Click a video to play it here.
More on PCR.
Funding Insights of Innoventric
Innoventric has successfully raised a total of $41.81M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $28.5 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41.81M
- Total Rounds 4
- Last Round Series B β $28.5M
- First Round $2.89M
(Nov 2021)
- Investors Count 6
All 4 funding rounds of Innoventric with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2024 | $28.5M | Series B | β | RA Capital Management | |
| Jun 2022 | $2.66M | Grant | β | β | |
| Nov 2021 | $2.89M | Grant | β | β | |
| Nov 2021 | $13.31M | Series A | β | EIC Fund | β |
6 investors in total: 6 institutional.
Investors in Innoventric
Innoventric has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, European Union and Mivtach Shamir Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment and technology solutions are provided by BRM Group. | brm.com | Tel Aviv, Israel | ||
Private fund focused on debt and equity investments in real estate, tech, energy, and multiple sectors | 1958 | msgroup.co.il | Tel Aviv, Israel | |
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
RA Capital is engaged in evidence-based investing in healthcare and life sciences. | 2004 | racap.com | Boston, United States | |
Provides diversified investment management services to clients. | 2017 | jginvest.com | Beijing, China | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Innoventric
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Innoventric
7 people are tracked at Innoventric (6 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Rafi Benary | Founder | Leadership |
David Planer | Founder & CMO | Leadership |
Amir Danino | Founder & CEO | Leadership |
yair pichersky | Head Of R&d | Leadership |
Eyal Kislev | Head Of Engineering | Leadership |
Einat Har | Chief Financial Officer | Leadership |
Michal Krieger | Office Manager | Team |
Complete people profiles for Innoventric
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Innoventric
3 dated milestones of Innoventric across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Innoventric is founded.
- Funding First funding round of $2.9M.
- Funding Latest funding round, Series B, of $28.5M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innoventric
Complete news archive for Innoventric
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innoventric
Innoventric was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Innoventric is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Innoventric is a funded company, having raised a total of $41.81M across 4 funding rounds to date. The company's 1st funding round was a Grant of $2.89M, raised on Nov 2021.
Founded in 2017 in Ness Ziona, Israel, transcatheter solutions are developed for patients with heart diseases. Focus is placed on percutaneous devices, including the Trillium, which addresses tricuspid regurgitation through minimally invasive procedures. Operations occur within the medical device sector, emphasizing cardiovascular treatments. Geography is centered in Israel, with activities aimed at advancing interventional cardiology options for clinical use.
Innoventric offers Trillium, Unica, and Koala.
Innoventric has 6 investors. Key investors include RA Capital, European Union, Mivtach Shamir Holdings, BRM, and JG Investment.
Innoventric operates through Innoventric Ltd..
